Signal from the log
First-in-class Takeda Protagonist
Le rusfertide de Takeda et Protagonist, commercialisé sous le nom de Mimrylo, obtient l'approbation de la FDA dans la polyglobulie de Vaquez. Approbation réglementaire entre deux sociétés cotées, hors périmètre : le signal reste de la matière pour un bloc pari, jamais un sujet.
Spotted Amount read from the headline
Announced on , logged by the watch of 31 August 2026.
- Operation
- Funding round
What the log says
Editorial note, in French
Repérée par la collecte. Personne ne l'a encore instruite.
What is missing before publishing
- No fund is publicly named. It is the first condition of the selection bar: without a named investor there is no round to tell.
- No public amount. A missing amount is never estimated or inferred from a filing.
- The stage of the round is not disclosed. A letter is never inferred from an amount or a track record.
Provenance
Source medcity
Logged on 31 August 2026
Description Written in French during the watch run. Based on the headline as relayed by the source, without reading the issuer's press release.
Verification The fields shown come from an automatic reading of the source headline. They have not yet been checked against the press release and should not be quoted as verified.
What this status means
Spotted The collection saw this operation and logged it. Nobody has processed it yet, so what is shown is still an automatic reading of the source headline.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.